3BEDNAREK PH, JENSEN JT. Safety, efficacy and patient acceptability of the contraceptive and non-contraceptive uses of the LNG-1US[ J]. Int J Womens Health,2010,1:45 -58.
4LETE I, CRISTOBAL I, FEBRER L, et al. Economic evaluation of the levonorgestrel-releasing intrauterine system for the treatment of dysfunctional uterine bleeding in Spain[ J]. Eur J Obstet Gynecol Reprad BioI,2011,154 ( 1 ) :7 1- 80.
5RIZKAUA HF, HIGGINS M, KELEHAN P, et al. Pathological findings associated with the presence of a Mirena intrauterine system at hysteretomy [ J ]. Int J Gynecol Pathol, 2008,27 ( 1 ) : 74 - 78.
6JIMENEZ MF, ARBO E, VETORI D, et al. The effect of the levonorgostrel releasing intrauterine system and the copper intrauterine device on subendomelrial microvaseularization and uterine artery blood flow[ J ]. Fertil Steril,2008,90 (5) :1574 - 1578.
7OZDEGIRMENEI O, KAYIKCIOGLU F, AKGUL MA, et al. Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis [ J ]. Fertil Steri1,2011,95 (2) :497 - 502.
